Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
NXbio Development AB
AB
Active
Org 5565121794
Storjordenvägen 2, 864 31
Matfors
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 1995 · 31 years old
2 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
NXbio Development AB
Overview
Financials
People & ownership
Related companies
Loading company…
Related companies
Company hierarchy
Flerie AB
91%
Flerie Invest AB
92%
NorthX Biologics Holding AB
100%
NXbio Development AB
(this company)
NorthX Biologics AB
100% owned
Board network connections
Board members of NXbio Development AB also hold positions in
1021
other companies.
Person
Role here
Other companies
Ann Charlott Bouvin
Chief Auditor
755 companies
Many roles
Robert Jan Hasslund
Chief Auditor
214 companies
Many roles
Thomas Bengt Eldered
External Signatory
28 companies
Many roles
Adriana Jannetje Hoogstraate
Board of Directors
7 companies
Many roles
Lars Christer Fahlander
Chief Executive Officer
5 companies
Sara Eva-Karin Sällstedt Gidlund
Deputy Board Member
5 companies
Ted Ingemar Jakob Fjällman
Deputy Board Member
2 companies
Jon Galli
Board of Directors
2 companies
Ida Helena Christina Strigård
Board of Directors
2 companies
Maria Ingrid Rynell
Chairman
1 company
More on NXbio Development AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
People & ownership →
Management, board and shareholder breakdown
Flerie AB
NXbio Development AB